---
title: "Donald L. Drakeman, Lisa N. Drakeman og Nektarios Oraiopoulos From Breakthrough to Blockbuster"
brand: "Donald L. Drakeman, Lisa N. Drakeman og Nektarios Oraiopoulos"
category: "Ukategoriseret"
price_min: 329
currency: DKK
vendor_count: 1
in_stock: true
url: https://pricetracker.dk/p/from-breakthrough-to-blockbuster-f9b6f1
last_checked: 2026-07-21
---

# Donald L. Drakeman, Lisa N. Drakeman og Nektarios Oraiopoulos From Breakthrough to Blockbuster

Mærke: Donald L. Drakeman, Lisa N. Drakeman og Nektarios Oraiopoulos · Kategori: Ukategoriseret

Sammenlign priser på Donald L. Drakeman, Lisa N. Drakeman og Nektarios Oraiopoulos From Breakthrough to Blockbuster fra 1 forhandler. Billigste pris nu: 329 kr hos Saxo DK. Se aktuelle priser og køb hos den billigste forhandler på https://pricetracker.dk/p/from-breakthrough-to-blockbuster-f9b6f1

## Priser
- **Billigste pris nu:** 329 kr hos Saxo DK

## Forhandlere
| Forhandler | Pris | Levering |
|---|---|---|
| Saxo DK | 329 kr | — |

## Om produktet
Financial Times Business Top Title March 2022 How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries? Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster: The Business of Biotechnology focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.

---

Kilde: PriceTracker. Fuld side med interaktiv prishistorik og købslinks: https://pricetracker.dk/p/from-breakthrough-to-blockbuster-f9b6f1
Priserne er sidst kontrolleret 2026-07-21.